Blog

Adult vs Pediatric Perspectives on the Treatment of Hodgkin Lymphoma: An Oxford Debate


Presentation Description:
Hodgkin Lymphoma affects both adults and children, but the approach to its treatment varies quite dramatically between these two populations. In this debate-style session, two pediatric oncology experts and two adult oncology specialists squared off to discuss their respective approaches to the treatment of Hodgkin Lymphoma, in the hopes of shedding new light on what the pediatric oncology community can learn from the adult oncologists who battle this disease, and vice versa.

Speakers (in presentation order):

Angela Punnett, MD, FRCPC
Staff Oncologist, Hospital for Sick Children, Toronto
Associate Education Program Director, Pediatric Haematology/Oncology
University of Toronto

Ann S. LaCasce, MD, MMSc
Program Director, Fellowship in Hematology/Oncology;
Lymphoma Program, Dana-Farber Cancer Institute, Boston
Assistant Professor of Medicine, Harvard Medical School, Boston

Kara Kelly, MD
Associate Director, Division of Pediatric Hematology/Oncology/Stem Cell Transplant
Columbia University, New York
Medical Center Chair, Hodgkin Lymphoma Committee, Children’s Oncology Group

John Kuruvilla, MD, FRCPC
Clinical Investigator, Department of Medical Oncology and Hematology
Princess Margaret Hospital, Toronto
Assistant Professor, University of Toronto

Comments are closed.